Salix Pharmaceuticals to Present at JMP Securities Healthcare Conference JMP Securities Healthcare Conference 2013 Business Wire RALEIGH, N.C. -- July 3, 2013 Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The 8^th Annual JMP Securities Healthcare Conference in New York, NY on Wednesday, July 10, 2013 at 10:00 a.m. Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location. Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company’s gastroenterology specialty sales and marketing team. Salix trades on the NASDAQ Global Select Market under the ticker symbol “SLXP”. For more information, please visit our Website at www.salix.com or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook (www.facebook.com/SalixPharma). Information on our web site is not incorporated in our SEC filings. Contact: Salix Pharmaceuticals, Ltd. Adam C. Derbyshire, 919-862-1000 Executive Vice President and Chief Financial Officer or G. Michael Freeman, 919-862-1000 Associate Vice President, Investor Relations and Corporate Communications
Salix Pharmaceuticals to Present at JMP Securities Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.